Onkure Therapeutics Inc
OKUR2.165USD
-0.035-1.59%
Close 08/04, 16:00（ET）Quotes delayed by 15 min
2.165USD+2.165After-hours 08/04, 20:00 (ET)
29.10MMarket Cap
LossP/E TTM
Onkure Therapeutics Inc
2.165
-0.035-1.59%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
Operating expenses
72.92%17.00M
35.15%33.80M
-77.67%4.66M
-69.75%6.36M
-39.02%9.83M
71.72%25.01M
50.92%20.89M
69.25%21.04M
23.88%16.12M
37.07%14.56M
8.53%13.84M
34.71%12.43M
80.41%13.02M
69.96%10.62M
150.09%12.75M
149.47%9.23M
60.24%7.21M
--6.25M
--5.10M
--3.70M
--4.50M
R&D expenses
51.90%13.01M
112.22%37.36M
-93.36%904.00K
-95.90%590.00K
-22.06%8.57M
69.97%17.60M
37.07%13.62M
77.08%14.40M
18.46%10.99M
45.87%10.36M
6.65%9.94M
29.51%8.13M
69.55%9.28M
38.73%7.10M
110.29%9.32M
122.90%6.28M
52.93%5.47M
--5.12M
--4.43M
--2.82M
--3.58M
Depreciation, depletion, and amortization
1225.00%212.00K
1313.64%622.00K
-72.09%12.00K
-71.43%12.00K
-60.98%16.00K
76.00%44.00K
95.45%43.00K
90.91%42.00K
115.79%41.00K
47.06%25.00K
69.23%22.00K
120.00%22.00K
90.00%19.00K
70.00%17.00K
44.44%13.00K
11.11%10.00K
11.11%10.00K
--10.00K
--9.00K
--9.00K
--9.00K
Operating profit
-72.92%-17.00M
-35.15%-33.80M
77.67%-4.66M
69.75%-6.36M
39.02%-9.83M
-71.72%-25.01M
-50.92%-20.89M
-69.25%-21.04M
-23.88%-16.12M
-37.07%-14.56M
-8.53%-13.84M
-34.71%-12.43M
-80.41%-13.02M
-69.96%-10.62M
-150.09%-12.75M
-149.47%-9.23M
-60.24%-7.21M
---6.25M
---5.10M
---3.70M
---4.50M
Net non-operating interest income (expenses)
Non-operating interest income
264.41%1.07M
--2.01M
----
----
--295.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Non-operating interest expense
----
--300.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Other non-operating income (expenses)
----
-314.33%-3.11M
-42.55%972.00K
-33.49%1.00M
12.01%1.14M
50.94%1.45M
103.12%1.69M
1167.23%1.51M
4938.10%1.02M
5558.82%962.00K
4800.00%833.00K
891.67%119.00K
-1150.00%-21.00K
950.00%17.00K
240.00%17.00K
0.00%12.00K
-97.18%2.00K
---2.00K
--5.00K
--12.00K
--71.00K
Income before tax
-67.00%-15.93M
-49.42%-35.19M
80.77%-3.69M
72.55%-5.36M
36.88%-9.54M
-73.19%-23.55M
-47.58%-19.20M
-58.63%-19.53M
-15.89%-15.11M
-28.22%-13.60M
-2.14%-13.01M
-33.59%-12.31M
-80.75%-13.04M
-69.63%-10.61M
-150.00%-12.73M
-149.96%-9.22M
-62.76%-7.21M
---6.25M
---5.09M
---3.69M
---4.43M
Income after tax
-67.00%-15.93M
-49.42%-35.19M
80.77%-3.69M
72.55%-5.36M
36.88%-9.54M
-73.19%-23.55M
-47.58%-19.20M
-58.63%-19.53M
-15.89%-15.11M
-28.22%-13.60M
-2.14%-13.01M
-33.59%-12.31M
-80.75%-13.04M
-69.63%-10.61M
-150.00%-12.73M
-149.96%-9.22M
-62.76%-7.21M
---6.25M
---5.09M
---3.69M
---4.43M
Net income from continuous operations
-67.00%-15.93M
-49.42%-35.19M
80.77%-3.69M
72.55%-5.36M
36.88%-9.54M
-73.19%-23.55M
-47.58%-19.20M
-58.63%-19.53M
-15.89%-15.11M
-28.22%-13.60M
-2.14%-13.01M
-33.59%-12.31M
-80.75%-13.04M
-69.63%-10.61M
-150.00%-12.73M
-149.96%-9.22M
-62.76%-7.21M
---6.25M
---5.09M
---3.69M
---4.43M
Net income attributable to controlling interests
-67.00%-15.93M
-49.42%-35.19M
80.77%-3.69M
72.55%-5.36M
36.88%-9.54M
-73.19%-23.55M
-47.58%-19.20M
-58.63%-19.53M
-15.89%-15.11M
-28.22%-13.60M
-2.14%-13.01M
-33.59%-12.31M
-80.75%-13.04M
-69.63%-10.61M
-150.00%-12.73M
-149.96%-9.22M
-62.76%-7.21M
---6.25M
---5.09M
---3.69M
---4.43M
Net income attributable to common shareholders
-67.00%-15.93M
-49.42%-35.19M
80.77%-3.69M
72.55%-5.36M
36.88%-9.54M
-73.19%-23.55M
-47.58%-19.20M
-58.63%-19.53M
-15.89%-15.11M
-28.22%-13.60M
-2.14%-13.01M
-33.59%-12.31M
-80.75%-13.04M
-69.63%-10.61M
-150.00%-12.73M
-149.96%-9.22M
-62.76%-7.21M
---6.25M
---5.09M
---3.69M
---4.43M
Basic earnings per share
96.09%-1.19
-33.38%-9.36
-94.52%-11.04
75.18%-1.60
-403.28%-30.37
-26.82%-7.02
-6.93%-5.68
-28.44%-6.46
-13.21%-6.03
-27.65%-5.54
-1.72%-5.31
-16.67%-5.03
-78.93%-5.33
-67.92%-4.34
-148.09%-5.22
-183.26%-4.31
-62.76%-2.98
---2.58
---2.10
---1.52
---1.83
Diluted earnings per share
96.09%-1.19
-33.38%-9.36
-94.52%-11.04
75.18%-1.60
-403.28%-30.37
-26.82%-7.02
-6.93%-5.68
-28.44%-6.46
-13.21%-6.03
-27.65%-5.54
-1.72%-5.31
-16.67%-5.03
-78.93%-5.33
-67.92%-4.34
-148.09%-5.22
-183.26%-4.31
-62.76%-2.98
---2.58
---2.10
---1.52
---1.83
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
